Xoma | Beban Penjualan Dan Administrasi



Selling And Administration Expenses Perubahan Tanggal
AbbVie USD 3.29B 562M 2025-03
Agios Pharmaceuticals USD 41.53M 10.17M 2025-03
Ardelyx USD 76.07M 11.1M 2024-12
BioMarin Pharmaceutical USD 206.12M 50.65M 2025-03
Celldex Therapeutics USD 10.82M 557K 2025-03
Eli Lilly USD 2.36B 62.3M 2025-03
Incyte USD 325.69M 1.02M 2025-03
Life Technologies USD 3.59M 256K 2024-12
MacroGenics USD 27.81M 13.71M 2024-12
Novartis USD 3.5B 368M 2024-12
Novartis USD 3.5B 368M 2024-12
Pfizer USD 3.01B 1.27B 2025-03
Prothena USD 16.85M 88K 2024-12
Regeneron Pharmaceuticals USD 633M 159.2M 2025-03



Xoma Beban Penjualan Dan Administrasi - Nilai saat ini, data historis, perkiraan, statistik, grafik dan kalender ekonomi - Jul 2025.